News & Updates
Showing Endocrinology articles
Showing

Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery
For patients with obesity and type 2 diabetes mellitus (T2DM) who are scheduled to undergo metabolic surgery, the presence of hypertension and hypercholesterolemia at baseline may predict failure of T2DM remission after the procedure, according to a study.

Obesity may induce RAAS activation in children
Obesity appears to play a major role in the activation of the renin‒angiotensin‒aldosterone system (RAAS), with a noticeable rise of angiotensin-converting enzyme (ACE) and ACE activities during childhood, reveals a recent study. In addition, sex differences are present in the association of ACE and ACE2 activities with blood pressure (BP).

HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.





